Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor Golgi-like expression

Journal of Comparative Neurology

Volumn 516, Issue 6, 2009, Pages 456-481

  van den Pol, Anthony N ^a   Ozduman, Koray ^a   Wollmann, Guido ^a   Ho, Winson S C ^a   Simon, Ian ^a   Yao, Yang ^a   Rose, John K ^a   Ghosh, Prabhat ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neuroanatomy; Neurophysiology; Rapid gene expression; Reporter gene; Virus

Indexed keywords

CALCIUM; FURA 2; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; RED FLUORESCENT PROTEIN; VIRUS RNA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; BRAIN ELECTROPHYSIOLOGY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; DIGITAL IMAGING; DROSOPHILA; EMBRYO; GENE DELETION; GENE EXPRESSION; GENETIC ENGINEERING; HAMSTER; HUMAN; HUMAN CELL; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MOUSE; NERVE FIBER; NEUROANATOMY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVIEW; RNA GENE; SUPRACHIASMATIC NUCLEUS; TRANSGENE; VESICULAR STOMATITIS VIRUS; VIRUS EXPRESSION; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; BRAIN; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NEUROGLIA; NEURONS; RNA, MESSENGER; RNA, VIRAL; TRANSGENES; VESICULOVIRUS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION; VIRUSES;

EID: 69449087624     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22131     Document Type: Review

References (164)

1. Ackman JB, Siddiqi F, Walikonis RS, LoTurco JJ. 2006. Fusion of microglia with pyramidal neurons after retroviral infection. J Neurosci 26:11413-11422.
2. Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, de Lecea L. 2007. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450:420-424.
3. Alemany R, Gomez-Manzano C, Balagué C, Yung WK, Curiel DT, Kyritsis AP, Fueyo J. 1999. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses. Exp Cell Res 252:1-12.
4. Allen C, Paraskevakou G, Liu C, Iankov ID, Msaouel P, Zollman P, Myers R, Peng KW, Russell SJ, Galanis E. 2008. Oncolytic measles virus strains in the treatment of gliomas. Expert Opin Biol Ther 8:213-220.
5. Aston-Jones G, Card JP. 2000. Use of pseudorabies virus to delineate multisynaptic circuits in brain: opportunities and limitations. J Neurosci Methods 103:51-61.
6. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. 2001. A neural circuit for circadian regulation of arousal. Nat Neurosci 4:732-738.
7. Baker KL, Daniels SB, Lennington JB, Lardaro T, Czap A, Notti RQ, Cooper O, Isacson O, Frasca S, Conover JC. 2006. Neuroblast protuberances in the subventricular zone of the regenerative MRL/mpj mouse. J Comp Neurol 498:747-761.
8. Banfield BW, Kaufman JD, Randall JA, Pickard GE. 2003. Development of pseudorabies virus strains expressing red fluorescent proteins: new tools for multisynaptic labeling applications. J Virol 77:10106-10112.
9. Barrett JW, Alston LR, Wang F, Stanford MM, Gilbert PA, Gao X, Jimenez J, Villeneuve D, Forsyth P, McFadden G. 2007. Identification of host range mutants of myxoma virus with altered oncolytic potential in human glioma cells. J Neurovirol 13:549-560.
10. Berns KI, Parrish CR. 2007. Parvoviridae. In: Griffin DM, Lab RA, Martin MA, Roizman B, Straus SE, editors. Fields virology, vol 2, 5th ed. Philadelphia: Lippincott Williams and Wilkins. p 2437-2477.
11. Boldogköi Z, Sík A, Dénes A, Reichart A, Toldi J, Gerendai I, Kovács KJ, Palkovits M. 2004. Novel tracing paradigms - genetically engineered herpesviruses as tools for mapping functional circuits within the CNS: present status and future prospects. Prog Neurobiol 72:417-445.
12. Boritz E, Gerlach J, Johnson JE, Rose JK. 1999. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J Virol 73:6937-6945.
13. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. 2005. Millisecond-time scale, genetically targeted optical control of neural activity. Nat Neurosci 8:1263-1268.
14. Brobeck JR. 1946. Mechanism of the development of obesity in animals with hypothalamic lesions. Physiol Rev 26:541-559.
15. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T. 1998. The neuropeptide Y/agouti gene-related protein (AgRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci U S A 95:15043-15048.
16. Brody SL, Crystal RG. 1994. Adenovirus-mediated in vivo gene transfer. Ann N Y Acad Sci 716:90-101.
17. Burrows RC, Wancio D, Levitt P, Lillien L. 1997. Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex. Neuron 19:251-267.
18. Campbell RE. 2007. Defining the gonadotrophin-releasing hormone neuronal network: transgenic approaches to understanding neurocircuitry. J Neuroendocrinol 19:561-573.
19. Campbell RE, Herbison AE. 2007. Definition of brainstem afferents to gonadotropin-releasing hormone neurons in the mouse using conditional viral tract tracing. Endocrinology 148:5884-5890.
20. Cao H, Zhang GR, Wang X, Kong L, Geller AI. 2008. Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles. BMC Neurosci 9:37.
21. Card JP, Whealy ME, Robbins AK, Moore RY, Enquist LW. 1991. Two alpha-herpesvirus strains are transported differentially in the rodent visual system. Neuron 6:957-969.
22. Card JP, Sved JC, Craig B, Raizada M, Vazquez J, Sved AF. 2006. Efferent projections of rat rostroventrolateral medulla C1 catecholamine neurons: Implications for the central control of cardiovascular regulation. J Comp Neurol 499:840-859.
23. Carmen IH. 2001. A death in the laboratory: the politics of the Gelsinger aftermath. Mol Ther 3:425-428.
24. Castro MG, Cowen R, Williamson IK, David A, Jimenez-Dalmaroni MJ, Yuan X, Bigliari A, Williams JC, Hu J, Lowenstein PR. 2003. Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther 98:71-108.
25. Cheli V, Adrover M, Blanco C, Ferrari C, Cornea A, Pitossi F, Epstein AL, Jerusalinsky D. 2006. Knocking-down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning. J Neurochem 97(Suppl 1):68-73.
26. Chen J, Wu J, Apostolova I, Skup M, Irintchev A, Kügler S, Schachner M. 2007. Adeno-associated virus-mediated L1 expression promotes functional recovery after spinal cord injury. Brain 130:954-969.
27. Chiocca EA, Aghi M, Fulci G. 2003. Viral therapy for glioblastoma. Cancer J 9:167-179.
28. Clarke DK, Nasar F, Lee M, Johnson JE, Wright K, Calderon P, Guo M, Natuk R, Cooper D, Hendry RM, Udem SA. 2007. Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations. J Virol 81:2056-2064.
29. Coker AL, Russell RB, Bond SM, Pirisi L, Liu Y, Mane M, Kokorina N, Gerasimova T, Hermonat PL. 2001. Adeno-associated virus is associated with a lower risk of high-grade cervical neoplasia. Exp Mol Pathol 70:83-89.
30. Csatary LK, Gosztonyi G, Szeberenyi J, Fabian Z, Liszka V, Bodey B, Csatary CM. 2004. MTH-68/H oncolytic viral treatment in human high-grade gliomas. J Neurooncol 67:83-93.
31. Dalton KP, Rose JK. 2001. Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. Virology 279:414-421.
32. DeFalco J, Tomishima M, Liu H, Zhao C, Cai X, Marth JD, Enquist L, Friedman JM. 2001. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science 291:2608-2613.
33. Desmaris N, Bosch A, Salaün C, Petit C, Prévost MC, Tordo N, Perrin P, Schwartz O, de Rocquigny H, Heard JM. 2001. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol Ther 4:149-156.
34. Dobrikova EY, Broadt T, Poiley-Nelson J, Yang X, Soman G, Giardina S, Harris R, Gromeier M. 2008. Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype. Mol Ther 16:1865-1872.
35. Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97:703-716.
36. Dotti CG, Simons K. 1990. Polarized sorting of viral glycoproteins to the axon and dendrites of hippocampal neurons in culture. Cell 62:63-72.
37. Duntsch CD, Zhou Q, Jayakar HR, Weimar JD, Robertson JH, Pfeffer LM, Wang L, Xiang Z, Whitt MA. 2004. Recombinant vesicular stomatitis virus vectors as oncolytic agents in the treatment of high-grade gliomas in an organotypic brain tissue slice-glioma coculture model. J Neurosurg 100:1049-1059.
38. Ehrengruber MU, Lundstrom K, Schweitzer C, Heuss C, Schlesinger S, Gähwiler BH. 1999. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci U S A 96:7041-7046.
39. Ehrengruber MU, Hennou S, Büeler H, Naim HY, Déglon N, Lundstrom K. 2001. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci 17:855-871.
40. Elmquist JK, Elias CF, Saper CB. 1999. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22:221-232.
41. Enquist LW, Card JP. 2003. Recent advances in the use of neurotropic viruses for circuit analysis. Curr Opin Neurobiol. 13:603-606.
42. Faulkner RL, Jang MH, Liu XB, Duan X, Sailor KA, Kim JY, Ge S, Jones EG, Ming GL, Song H, Cheng HJ. 2008. Development of hippocampal mossy fiber synaptic outputs by new neurons in the adult brain. Proc Natl Acad Sci U S A 105:14157-14162.
43. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. 2009. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27:59-65.
44. Fraefel C, Breakefield XO, Jacoby DR. 1998. HSV-1 Amplicon. In: Chiocca EA, Breakefield XO, editors. Gene therapy for neurological disorders and brain tumors. Totowa, NJ: Humana Press. p 63-82.
45. Fu LY, van den Pol AN. 2008. Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons. J Neurosci 28:5433-5449.
46. Gao Y, Whitaker-Dowling P, Watkins SC, Griffin JA, Bergman I. 2006. Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line. J Virol 80:8603-8612.
47. Glatzer NR, Derbenev AV, Banfield BW, Smith BN. 2007. Endomorphin-1 modulates intrinsic inhibition in the dorsal vagal complex. J Neurophysiol 98:1591-1599.
48. Glorioso JC, Fink DJ. 2004. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol 58:253-271.
49. Grieger JC, Samulski RJ. 2005. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99:119-145.
50. Grinevich V, Brecht M, Osten P. 2005. Monosynaptic pathway from rat vibrissa motor cortex to facial motor neurons revealed by lentivirus-based axonal tracing. J Neurosci 25:8250-8258.
51. Guigoni C, Coulon P. 2002. Rabies virus is not cytolytic for rat spinal motoneurons in vitro. J Neurovirol 8:306-317.
52. Haberman RP, Samulski RJ, McCown TJ. 2003. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9:1076-1080.
53. 2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419.
54. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118:3132-3142.
55. Hioki H, Kameda H, Nakamura H, Okunomiya T, Ohira K, Nakamura K, Kuroda M, Furuta T, Kaneko T. 2007. Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. Gene Ther 14:872-882.
56. Ho WSC, van den Pol AN. 2007. Bystander attenuation of neuronal and astrocyte intercellular communication by murine cytomegalovirus infection of glia. J Virol 81:7286-7292.
57. Howorth PW, Teschemacher AG, Pickering AE. 2009. Retrograde adenoviral vector targeting of nociresponsive pontospinal noradrenergic neurons in the rat in vivo. J Comp Neurol 512:141-157.
58. Jacob JM, Zhou Q, Liu Y. 2000. Novel method for the labeling of distant neuromuscular junctions. J Neurosci Res 61:61-66.
59. Jakobsson J, Lundberg C. 2006. Lentiviral vectors for use in the central nervous system. Mol Ther 13:484-493.
60. Jasmin L, Burkey AR, Card JP, Basbaum AI. 1997. Transneuronal labeling of a nociceptive pathway, the spino-(trigemino-)parabrachioamygdaloid, in the rat. J Neurosci 17:3751-3765.
61. Jeetendra E, Robison CS, Albritton LM, Whitt MA. 2002. The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol 76: 12300-12311.
62. Kafri T, van Praag H, Gage FH, Verma IM. 2000. Lentiviral vectors: regulated gene expression. Mol Ther 1:516-21.
63. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. 1994. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148-154.
64. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ. 2007. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 369:2097-2105.
65. Kelly RM, Strick PL. 2000. Rabies as a transneuronal tracer of circuits in the central nervous system. J Neurosci Methods 103:63-71.
66. Kinoshita N, Mizuno T, Yoshihara Y. 2002. Adenovirus-mediated WGA gene delivery for transsynaptic labeling of mouse olfactory pathways. Chem Senses 27:215-223.
67. Klupp BG, Hengartner CJ, Mettenleiter TC, Enquist LW. 2004. Complete, annotated sequence of the pseudorabies virus genome. J Virol 78: 424-440.
68. Knapp AC, Enquist LW. 1997. Pseudorabies virus recombinants expressing functional virulence determinants gE and gI from bovine herpesvirus 1.1. J Virol 71:2731-2739.
69. Kretzschmar E, Peluso R, Schnell MJ, Whitt MA, Rose JK. 1996. Normal replication of vesicular stomatitis virus without C proteins. Virology 216:309-316.
70. Kuo H, Ingram DK, Crystal RG, Mastrangeli A. 1995. Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies. Brain Res 705: 31-38.
71. Lane MA, White TE, Coutts MA, Jones AL, Sandhu MS, Bloom DC, Bolser DC, Yates BJ, Fuller DD, Reier PJ. 2008. Cervical prephrenic interneurons in the normal and lesioned spinal cord of the adult rat. J Comp Neurol 511:692-709.
72. Lawson ND, Stillman EA, Whitt MA, Rose JK. 1995. Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 92:4477-4481.
73. Lee JW, Erskine MS. 2000. Pseudorabies virus tracing of neural pathways between the uterine cervix and CNS: effects of survival time, estrogen treatment, rhizotomy, and pelvic nerve transection. J Comp Neurol 418:484-503.
74. Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH. 1982. Is the acetyl-choline receptor a rabies virus receptor? Science 215:182-184.
75. Livet J, Weissman TA, Kang H, Draft RW, Lu J, Bennis RA, Sanes JR, Lichtman JW. 2007. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450:56-62.
76. Liu M, Tang J, Wang X, Yang T, Geller AI. 2005. Enhanced long-term expression from helper virus-free HSV-1 vectors packaged in the presence of deletions in genes that modulate the function of VP16, U L 46 and U L 47. J Neurosci Methods 145:1-9.
77. Liu M, Thankachan S, Kaur S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Neve R, Shiromani PJ. 2008. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 28:1382-1393.
78. Liu B, Wang S, Brenner M, Paton JF, Kasparov S. 2008. Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain. J Gene Med 10:583-592.
79. Lo WD, Qu G, Sferra TJ, Clark R, Chen R, Johnson PR. 1999. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther 10: 201-213.
80. Loewy AD. 1998. Viruses as transneuronal tracers for defining neural circuits. Neurosci Biobehav Rev 22:679-684.
81. Lowenstein PR, Suwelack D, Hu J, Yuan X, Jimenez-Dalmaroni M, Goverdhana S, Castro MG. 2003. Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders. Int Rev Neurobiol 55:3-64.
82. Lun X, Senger DL, Alain T, Oprea A, Parato K, Stojdl D, Lichty B, Power A, Johnston RN, Hamilton M, Parney I, Bell JC, Forsyth PA. 2006. Effects of intravenously administered recombinant vesicular stomatitis virus [VSV(deltaM51)] on multifocal and invasive gliomas. JNCI 98:1546-1557.
83. Lundh B. 1990. Spread of vesicular stomatitis virus along the visual pathways after retinal infection in the mouse. Acta Neuropathol 79: 395-401.
84. Lyles DS, Rupprecht CE. 2006. Rhabdoviridae. In: Fields BN, Knipe DM, Howley PM, Griffin DE, editors. Fields virology. Philadelphia: Lippincot Williams and Wilkins. p 1363-1408.
85. Mao H, Rosenthal KS. 2003. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential. J Virol 77:3409-3417.
86. Markert JM, Liechty PG, Wang W, Gaston S, Braz E, Karrasch M, Nabors LB, Markiewicz M, Lakeman AD, Palmer CA, Parker JN, Whitley RJ, Gillespie GY. 2009. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre- and posttumor resection for recurrent GBM. Mol Ther 17:199-207.
87. Martuza RL. 1992. Molecular neurosurgery for glial and neuronal disorders. Stereotactic Funct Neurosurg 59:92-99.
88. Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL, Carter EE, Barber RD, Baban DF, Kingsman SM, Kingsman AJ, O'Malley K, Mitrophanous KA. 2001. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 10:2109-2121.
89. McCarty DM, Young SM Jr, Samulski RJ. 2004. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet 38:819-845.
90. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713:99-107.
91. McGettigan JP, Pomerantz RJ, Siler CA, McKenna PM, Foley HD, Dietzschold B, Schnell MJ. 2003. Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic. J Virol 77:237-244.
92. Mebatsion T, Konig M, Conzelmann KK. 1996. Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 84:941-951.
93. Michel U, Malik I, Ebert S, Bähr M, Kügler S. 2005. Long-term in vivo and in vitro AAV-2-mediated RNA interference in rat retinal ganglion cells and cultured primary neurons. Biochem Biophys Res Commun 326: 307-312.
94. Millhouse OE. 1973a. The organization of the ventromedial hypothalamic nucleus. Brain Res 55:71-87.
95. Millhouse OE. 1973b. Certain ventromedial hypothalamic afferents. Brain Res 55:89-105.
96. Miller MA, Lavine CL, Klas SD, Pfeffer LM, Whitt MA. 2004. Recombinant replication-restricted VSV as an expression vector for murine cytokines. Protein Expr Purif 33:92-103.
97. Mocarski E. 1996. Cytomegaloviruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven Publishers. p 2447-2492.
98. Mocarski ES, Post LE, Roizman B. 1980. Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell 22:243-255.
99. Moriyoshi K, Richards LJ, Akazawa C, O'Leary DD, Nakanishi S. 1996. Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP. Neuron 16:255-260.
100. Naldini L. 1998. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr Opin Biotechnol 9:457-463.
101. Noé F, Nissinen J, Pitkänen A, Gobbi M, Sperk G, During M, Vezzani A. 2007. Gene therapy in epilepsy: the focus on NPY. Peptides 28:377-383.
102. Noël G, Zollinger L, Laliberté F, Rassart E, Crine P, Boileau G. 1989. Targeting and processing of proopiomelanocortin in neuronal cell lines. J Neurochem 52:1050-1057.
103. Norgren RB, Lehman MN. 1998. Herpes simplex virus as a transneuronal tracer. Neurosci Biobehav Rev 22:695-708.
104. 2+ elevating to depressing. J Neurosci 15:5065-5078.
105. Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J. 2003. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol 10:154-160.
106. Ozduman K, Wollmann G, Peipmeier J, van den Pol AN. 2008. Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain. J Neurosci 28:1882-1893.
107. Peltékian E, Parrish E, Bouchard C, Peschanski M, Lisovoski F. 1997. Adenovirus-mediated gene transfer to the brain: methodological assessment. J Neurosci Methods 71:77-84.
108. Publicover J, Ramsburg E, Rose JK. 2004. Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses. J Virol 78:9317-9324.
109. Publicover J, Ramsburg E, Robek M, Rose JK. 2006. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. J Virol 80:7028-7036.
110. Pulkkanen KJ, Yla-Herttuala S. 2005. Gene therapy for malignant glioma: current clinical status. Mol Ther 12:585-598.
111. Quinonez R, Sutton RE. 2002. Lentiviral vectors for gene delivery into cells. DNA Cell Biol 21:937-951.
112. Rainov NG, Ren H. 2003. Oncolytic viruses for treatment of malignant brain tumours. Acta Neurochir Suppl 88:113-123.
113. Rainov NG, Kramm CM, Banning U, Riemann D, Holzhausen HJ, Heidecke V, Burger KJ, Burkert W, Körholz D. 2000. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme. Gene Ther 7:1853-1858.
114. Ramsburg E, Publicover J, Buonocore L, Poholek A, Robek M, Palin A, Rose JK. 2005. A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J Virol 79:15043-15053.
115. Rasmussen M, Kong L, Zhang GR, Liu M, Wang X, Szabo G, Curthoys NP, Geller AI. 2007. Glutamatergic or GABAergic neuron-specific, longterm expression in neocortical neurons from helper virus-free HSV-1 vectors containing the phosphate-activated glutaminase, vesicular glutamate transporter-1, or glutamic acid decarboxylase promoter. Brain Res 1144:19-32.
116. Ray N, Enquist LW. 2004. Transcriptional response of a common permissive cell type to infection by two diverse alphaherpesviruses. J Virol 78:3489-3501.
117. Reiss CS, Plakhov IV, Komatsu T. 1998. Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain. Ann N Y Acad Sci 855:751-761.
118. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A. 2004. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 24: 3051-3059.
119. Ridoux V, Robert JJ, Zhang X, Perricaudet M, Mallet J, Le Gal La Salle G. 1994. Adenovirus vectors as functional retrograde neuronal tracers. Brain Res 648:171-175.
120. Rinaman L, Levitt P, Card JP. 2000. Progressive postnatal assembly of limbic-autonomic circuits revealed by central transneuronal transport of pseudorabies virus. J Neurosci 20:2731-2741.
121. Roberts TF, Klein ME, Kubke MF, Wild JM, Mooney R. 2008. Telencephalic neurons monosynaptically link brainstem and forebrain premotor networks necessary for song. J Neurosci 28:3479-3489.
122. Ruigrok TJ, Pijpers A, Goedknegt-Sabel E, Coulon P. 2008. Multiple cerebellar zones are involved in the control of individual muscles: a retrograde transneuronal tracing study with rabies virus in the rat. Eur J Neurosci 28:181-200.
123. Salin P, Castle M, Kachidian P, Barroso-Chinea P, López IP, Rico AJ, Kerkerian-Le Goff L, Coulon P, Lanciego JL. 2008. High-resolution neuroanatomical tract-tracing for the analysis of striatal microcircuits. Brain Res 1221:49-58.
124. Sato Y, Shiraishi Y, Furuichi T. 2004. Cell specificity and efficiency of the Semliki forest virus vector- and adenovirus vector-mediated gene expression in mouse cerebellum. J Neurosci Methods 137:111-121.
125. Schnell MJ, Johnson JE, Buonocore L, Rose JK. 1997. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90:849-857.
126. Seiler MJ, Thomas BB, Chen Z, Wu R, Sadda SR, Aramant RB. 2008. Retinal transplants restore visual responses: trans-synaptic tracing from visually responsive sites labels transplant neurons. Eur J Neurosci 28:208-220.
127. Sharpe AH, Hunter JJ, Chassler P, Jaenisch R. 1990. Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature 346:181-183.
128. Shepherd GM, Greer CA. 1998. The olfactory bulb. In: Shepherd G, editor. The synaptic organization of the brain, 4th ed. New York: Oxford University Press. p 159-203.
129. Smith BN, Banfield BW, Smeraski CA, Wilcox CL, Dudek FE, Enquist LW, Pickard GE. 2000. Pseudorabies virus expressing enhanced green fluorescent protein: A tool for in vitro electrophysiologicalanalysis of transsynaptically labeled neurons in identified central nervous system circuits. Proc Natl Acad Sci U S A 97:9264-9269.
130. Smith C, Lachmann RH, Efstathiou S. 2000. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system. J Gen Virol 81:649-662.
131. Sofroniew MV, Weindl A, Schrell U, Wetzstein R. 1981. Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain. Acta Histochem Suppl 24:79-95.
132. Song CK, Schwartz GJ, Bartness TJ. 2009. Anterograde transneuronal viral tract tracing reveals central sensory circuits from white adipose tissue. Am J Physiol Regul Integr Comp Physiol 296:R501-511.
133. Stettler DD, Yamahachi H, Li W, Denk W, Gilbert CD. 2006. Axons and synaptic boutons are highly dynamic in adult visual cortex. Neuron 49:877-887.
134. Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott J, Bell JC. 2003. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263-275.
135. Sun N, Cassell MD, Perlman S. 1996. Anterograde, transneuronal transport of herpes simplex virus type 1 strain H129 in the murine visual system. J Virol 70:5405-5413.
136. Taber KH, Strick PL, Hurley RA. 2005. Rabies and the cerebellum: new methods for tracing circuits in the brain. J Neuropsychiatry Clin Neurosci 17:133-139.
137. Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L, Wilson JM, Debyser Z, Baekelandt V. 2007. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18:195-206.
138. Terashima T, Miwa A, Kanegae Y, Saito I, Okado H. 1997. Retrograde and anterograde labeling of cerebellar afferent projection by the injection of recombinant adenoviral vectors into the mouse cerebellar cortex. Anat Embryol 196:363-382.
139. Tsukamoto Y, Yamamoto T, Okado H, Nibu K, Terashima T. 2003. Retrograde labeling of mouse spinal descending tracts by a recombinant adenovirus. Arch Histol Cytol 66:209-220.
140. Ugolini G. 1995. Specificity of rabies virus as a transneuronal tracer of motor networks: transfer from hypoglossal motoneurons to connected second-order and higher order central nervous system cell groups. J Comp Neurol 356:457-480.
141. Ugolini G. 2008. Use of rabies virus as a transneuronal tracer of neuronal connections: implications for the understanding of rabies pathogenesis. Dev Biol 131:493-506.
142. Ugolini G, Kuypers HG, Simmons A. 1987. Retrograde transneuronal transfer of herpes simplex virus type 1 (HSV 1) from motoneurones. Brain Res 422:242-256.
143. van den Pol AN. 2006. Viral infections in the developing and mature brain. Trends Neurosci 29:398-406.
144. van den Pol AN, Ghosh P. 1998. Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice. J Neurosci 18:10640-10651.
145. van den Pol AN, Mocarski E, Saederup N, Vieira J, Meier TJ. 1999. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J Neurosci 19:10948-10965.
146. van den Pol AN, Vieira J, Spencer DD, Santarelli JG. 2000. Mouse cytomegalovirus in developing brain tissue - analysis of 11 species with GFP-expressing recombinant virus. J Comp Neurol 427:559-580.
147. van den Pol AN, Dalton K, Rose J. 2002a. Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein. J Virol 76:1309-1327.
148. van den Pol AN, Reuter J, Santarelli J. 2002b. Enhanced cytomegalovirus infection of the developing brain independent of the adaptive immune system. J Virol 76:8842-8854.
149. van den Pol AN, Acuna C, Clark R, Ghosh PK. 2004. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 42:635-652.
150. Van Doren K, Hanahan D, Gluzman Y. 1984. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol 50:606-614.
151. Virta S, Rapola J, Jalanko A, Laine M. 2006. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse. J Gene Med 8:699-706.
152. Wagner RR, Rose JK. 1996. Rhabdoviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 3rd ed. New York: Lippincott-Raven. p 1121-1131.
153. Walsh C, Cepko CL. 1993. Clonal dispersion in proliferative layers of developing cerebral cortex. Nature 362:632-635.
154. Watts AG, Swanson LW, Sanchez-Watts G. 1987. Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J Comp Neurol 258:204-229.
155. Wickersham IR, Lyon DC, Barnard RJO, Mori T, Finke S, Conzelmann KK, Young JAT, Callaway EM. 2007a. Monosynaptic restriction of trans-synaptic tracing from single, genetically targeted neurons. Neuron 53:639-647.
156. Wickersham IR, Finke S, Conzelmann KK, Callaway EM. 2007b. Retrograde neuronal tracing with a deletion mutant rabies virus. Nature Methods 4:47-49.
157. Wilcox ME, Yang W, Senger D, Rewcastle NB, Morris DG, Brasher PM, Shi ZQ, Johnston RN, Nishikawa S, Lee PW, Forsyth PA. 2001. Reovirus as an oncolytic agent against experimental human malignant gliomas. JNCI 93:903-912.
158. Wintermantel TM, Campbell RE, Porteous R, Bock D, Gröne HJ, Todman MG, Korach KS, Greiner E, Pérez CA, Schütz G, Herbison AE. 2006. Definition of estrogen receptor pathway critical for estrogen postive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52:271-280.
159. Wollmann G, Tattersall P, van den Pol AN. 2005. Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J Virol 79:6005-6022.
160. Wong LF, Goodhead L, Prat C, Mitrophanous KA, Kingsman SM, Mazarakis ND. 2006. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 17:1-9.
161. Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A, Fitzsimons H, Choi KL, Ma H, Dragunow M, Leone P, Chen Q, Dicker B, During MJ. 2001. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther 8:1323-1332.
162. Yates BJ, Smail JA, Stocker SD, Card JP. 1999. Transneuronal tracing of neural pathways controlling activity of diaphragm motoneurons in the ferret. Neuroscience 90:1501-1513.
163. Yoon H, Enquist LW, Dulac C. 2005. Olfactory inputs to hypothalamic neurons controlling reproduction and fertility. Cell 123:669-682.
164. Zemanick MC, Strick PL, Dix RD. 1991. Direction of transneuronal transport of herpes simplex virus 1 in the primate motor system is strain-dependent. Proc Natl Acad Sci U S A 88:8048-8051.